Bea JW, et al. O-075. Presented at: ObesityWeek; Nov. 1-4, 2022; San Diego. Disclosures: Bea reports serving as a consultant for WHI and receiving funding from Disarm Therapeutics for an investigator-initiated trial to study biomarkers of chemotherapy-induced peripheral neuropathy among patients with taxane-treated breast cancer. SAN DIEGO — Higher amounts of visceral and subcutaneous adipose Read more…